- Home
- MGTX vs PHK Comparison
MGTX vs PHK Comparison
Compare MGTX & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.57
Company Overview
Basic Information| Metric | MGTX | PHK |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.9M | 842.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MGTX | PHK |
|---|---|---|
| Price | $8.57 | $4.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $23.83 | N/A |
| AVG Volume (30 Days) | ★ 706.5K | 491.5K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,417,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $619.95 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 96.83 | N/A |
| 52 Week Low | $4.55 | $4.13 |
| 52 Week High | $9.73 | $5.15 |
Technical Indicators
Market Signals| Indicator | MGTX | PHK |
|---|---|---|
| Relative Strength Index (RSI) | 57.48 | 58.80 |
| Support Level | $7.60 | $4.87 |
| Resistance Level | $8.34 | $4.91 |
| Average True Range (ATR) | 0.51 | 0.03 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 91.81 | 91.05 |
Price Performance
Historical Comparison MGTX
PHK
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.